During epithelial–mesenchymal transition (EMT), a key process in cancer progression, MMP-1 and MMP-2 secretion is significantly upregulated, leading to collagen IV fragmentation and destruction of the BM niche in invasive skin cancers [131]. The gene discussed is MMP2; the disease is cancer.